HomeTagsMP1032

MP1032

Popular

Must Read

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Latest Articles

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Press Releases 0
MetrioPharm announced today that the European Medicines Agency has...

Genethon to Launch Pivotal Trial in Europe of GNT0004 a Low-Dose Microdystrophin Gene Therapy for Duchenne Muscular Dystrophy

Research 1
Genethon has received approvals from regulatory authorities, MHRA and...

FDA: ‘Elevidys Gene Therapy Will Continue to Be Used in Ambulatory DMD Patients’

Press Releases 0
Elevidys, a gene therapy for Duchenne Muscular Dystrophy (DMD)...

Most Popular

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Treatments 5
A genetic condition known as Duchenne muscular dystrophy (DMD)...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Research 6
The results of new gene therapy studies for Duchenne...

Duchenne Muscular Dystrophy: Treatment & Cost

Editorials 1
The excitement you feel until your child is born...

© 2024 - 2025 DMD Warrior. All rights reserved.